Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine
Open accessThe DOI matches its Crossref record; 234 of the 235 references it cites were found in a registry or an index.
Abstract
Earlier research primarily attributed the effects of mesenchymal stem cell (MSC) therapies to their capacity for local engrafting and differentiating into multiple tissue types. However, recent studies have revealed that implanted cells do not survive for long, and that the benefits of MSC therapy could be due to the vast array of bioactive factors they produce, which play an important role in the regulation of key biologic processes. Secretome derivatives, such as conditioned media or exosomes, may present considerable advantages over cells for manufacturing, storage, handling, product shelf life and their potential as a ready-to-go biologic product. Nevertheless, regulatory requirements for manufacturing and quality control will be necessary to establish the safety and efficacy profile of these products. Among MSCs, human uterine cervical stem cells (hUCESCs) may be a good candidate for obtaining secretome-derived products. hUCESCs are obtained by Pap cervical smear, which is a less invasive and painful method than those used for obtaining other MSCs (for example, from bone marrow or adipose tissue). Moreover, due to easy isolation and a high proliferative rate, it is possible to obtain large amounts of hUCESCs or secretome-derived products for research and clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766 · cited 1×
“The Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy established in 2006 the minimal identifying characteristics for human MSCs [29]: (a) plastic-adherent cells when maintained in standard culture conditions; (b) expression of CD105, CD73 and CD90, and lack expression of CD4…”
BackgroundValadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo
Gronthos, S., Mankani, M., Brahim, J., Robey, P. G., & Shi, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240309797 · Cited by 4,570 · cited 1×
“They have also been isolated from other adult tissues such as adipose tissue [10], skin [11], lung [12], synovial membrane [13], dental pulp [14], nasal olfactory mucosa [15], breast milk [16], scalp tissue [17], muscle [18], periosteum [19], corneal limbus [20], peripheral blood [21], endometrial and menstrual blood…”
BackgroundA perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991 · cited 1×
“All of these MCSs can be isolated and expanded from stroma of many tissues, the bone marrow and subcutaneous fat being the preferred sources [28].”
BackgroundDi Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., & Gianni, A. M. (2002) · Blood · doi:10.1182/blood.v99.10.3838 · Cited by 3,226 · cited 1×
“found that MSCs inhibit proliferation of CD4+ and CD8+ T cells [78].”
BackgroundMesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734 · cited 1×
“The most promising potential applications involve the treatment of graft versus host disease [74,75], as well as of autoimmune and inflammatory diseases, such as insulin systemic lupus erythematosus (SLE), diabetes mellitus type I, (SLE), multiple sclerosis or Crohn’s”
BackgroundFriedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970) · Cell Proliferation · doi:10.1111/j.1365-2184.1970.tb00347.x · Cited by 2,724 · cited 1×
“[9], who described a fibroblast-like population able to secrete growth factors and cytokines relevant for hematopoiesis and others processes.”
BackgroundNémeth, K., Leelahavanichkul, A., Yuen, P. S. T., Mayer, B., Parmelee, A., Doi, K., Robey, P. G., Leelahavanichkul, K., Koller, B. H., Brown, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1905 · Cited by 2,364
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302 · cited 1×
“This is relevant because CAFs, a prevailing component of tumor stroma, contribute to tumor growth, invasion and dissemination [145,146].”
Background
Research works printed but not linked: 1
- 95. Litwack G. Human Biochemistry and Disease. Academic Press; Cambridge, MA, USA: 2008.
Cited by
Items 601–700 of 1,000
Blangy‐Letheule, A., Persello, A., Rozec, B. R., WAARD, M. M. D., & Lauzier, B. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6681073 · Cited by 14
“Thus, any alteration in the release of a given protein and the abundance of such a protein in a given environment could reflect a pathological state [27].”
BackgroundMechanisms and therapeutic strategies linking mesenchymal stem cells senescence to osteoporosis
Tong, Y., Tu, Y., Wang, J., Liu, X., Su, Q., Wang, Y., & Wang, W. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1625806 · Cited by 19
“…class of pluripotent progenitor cells, are widely distributed in bone Cellular senescence is closely linked to various age-related marrow (9), adipose tissue (10), umbilical cord blood (11), and diseases, particularly playing a key role in bone metabolic disorders such With the dental…”
Xu, J., Wang, W., Wang, Y., Zhu, Z., Li, D., Wang, T., & Liu, K. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.929231 · Cited by 14
“The biomolecular cargo in the exosomes changes under different pathological conditions, such as hypoxia and inflammation (Vizoso et al., 2017).”
BackgroundRibeiro, R. D. C., Bom, S., Martins, A. M., Ribeiro, H. M., Santos, C. F., & Marto, J. M. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01294-y · Cited by 13
Efficacy of stem cell secretome loaded in hyaluronate sponge for topical treatment of psoriasis
Carrillo, D. G., Edwards, N., Arancibia‐Altamirano, D., Otárola, F. A., Villarroel, C., Prieto, C. P., Villamizar‐Sarmiento, M. G., Sauma, D., Valenzuela, F., Lattus, J. M., et al. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10443 · Cited by 13
Tan, F., Xu, M., Li, X., Wang, Z., Li, J., & Shahzad, K. A. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202300387 · Cited by 14
Cillo, U., Lonati, C., Bertacco, A., Magnini, L., Battistin, M., Ventrella, D., Aniballi, C., Carbonaro, M., Carlin, A., Elmi, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55217-7 · Cited by 14
Extracellular vesicles: essential agents in critical bone defect repair and therapeutic enhancement
Emami, A., Arabpour, Z., & Izadi, E. (2025) · Molecular Biology Reports · doi:10.1007/s11033-024-10209-0 · Cited by 13
“Research indicates that EVs induce the expression of factors associated with angiogenesis [104], tube formation, and stimulation of endothelial cell migration, thereby fostering angiogenesis near tendon-to-bone junctions [105].”
Nakamura, M., Nishida, H., Yoshizaki, K., Akiyoshi, H., Hatoya, S., Sugiura, K., & Inaba, T. (2020) · Journal of Veterinary Medical Science · doi:10.1292/jvms.19-0141 · Cited by 13
“The off-the-shelf secretome therapies could be immediately available for treatment of acute condition [25].”
BackgroundInfluentialEiró, N., Cabrera, J. R., Fraile, M., Costa, L. A., & Vizoso, F. J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00645 · Cited by 16
Self-citationInflammation, a Common Mechanism in Frailty and COVID-19, and Stem Cells as a Therapeutic Approach
Becerra, J., & Durán, I. (2021) · Stem Cells Translational Medicine · doi:10.1002/sctm.21-0074 · Cited by 14
Cao, C., Zhang, L., Liu, F., & Shen, J. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s372046 · Cited by 14
Katahira, Y., Murakami, F., Inoué, S., Miyakawa, S., Sakamoto, E., Furusaka, Y., Watanabe, A., Sekine, A., Kuroda, M., Hasegawa, H., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1010700 · Cited by 13
Hodge, J., Robinson, J. L., & Mellott, A. J. (2023) · Frontiers in Medical Technology · doi:10.3389/fmedt.2023.1194314 · Cited by 13
Hladkykh, F. V. (2023) · Clinical and Preventive Medicine · doi:10.31612/2616-4868.6.2023.15 · Cited by 13
Bryukhovetskiy, I., Ponomarenko, A. I., Lyakhova, I., Zaitsev, S., Zayats, Y., Korneyko, M., Елисейкина, М. Г., Mischenko, P., Шевченко, В. Е., Sharma, H. S., et al. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3668 · Cited by 13
“The highest hopes for developing new strategies in oncology and regenerative medicine lie with the MSc secretome (103).”
Ribeiro, T. O., Silveira, B. M. D., Meira, M. C., Carreira, A. C. O., Sogayar, M. C., Meyer, R., & Fortuna, V. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222093 · Cited by 17
“Discrimination of which of these components is more effective in producing therapeutic effects is still matter of debate [40, 41, 43].”
Titania Nanofiber Scaffolds with Enhanced Biointegration Activity—Preliminary In Vitro Studies
Ehlert, M., Roszek, K., Jędrzejewski, T., Bartmański, M., & Radtke, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225642 · Cited by 13
“Recent studies also point to the paracrine and trophic effects of mesenchymal stem cells, which allow them to influence the neighboring microenvironment and provide a new prospective on cell-based therapy and tissue regeneration [75].”
BackgroundNguyen, Q. T., Dinh, N. T. H., Hang, N. T., Mão, C. V., Do, X.-H., Le, D. S., Dao, H., Giang, T. N., Forsyth, N. R., Hoang, V. T., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-20121-7 · Cited by 15
Ge, S., He, W., Zhang, L., Lin, S., Luo, Y., Chen, Q., & Zeng, M. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111612 · Cited by 12
Zhao, Q., Larios, K., Naaldijk, Y., Sherman, L. S., Chemerinski, A., Okereke, K., Rameshwar, P., Lemenze, A. D., Douglas, N. C., & Morelli, S. S. (2023) · Reproduction · doi:10.1530/rep-22-0485 · Cited by 14
Liu, W., Wu, J., Cao, H., Ma, C., Wu, Z., Tian, Y., Ma, C., Qiu, H. Y., & Pan, G. (2023) · Stem Cells and Development · doi:10.1089/scd.2023.0110 · Cited by 13
“Previous studies have mainly focused on the application of stem cell-and primary hepatocyte-derived EVs [9,10].”
Zhao, F., Yang, T., Zhou, L., Zhao, J., Liu, J., Ping, W., Zhou, C., Qin, Z., & Jia, R. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.05.041 · Cited by 14
Revolutionizing orofacial pain management: the promising potential of stem cell therapy
Ren, K., Vickers, R., Murillo, J., & Ruparel, N. B. (2023) · Frontiers in Pain Research · doi:10.3389/fpain.2023.1239633 · Cited by 16
Sieńko, D., Szabłowska‐Gadomska, I., Nowak-Szwed, A., Rudziński, S., Gofron, M., Zygmunciak, P., Lewandowska-Szumieł, M., Zgliczyński, W., Czupryniak, L., & Mrozikiewicz‐Rakowska, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212171 · Cited by 12
“However, the use of cells has the advantage that their secretome may vary depending on changing environmental conditions [82].”
Giannasi, C., Cadelano, F., Morte, E. D., Baserga, C., Mazzucato, C., Niada, S., & Baj, A. (2024) · Biology · doi:10.3390/biology13121016 · Cited by 16
Vahed, S. Z., Hejazian, S. M., Bakari, W. N., Landon, R., Gueguen, V., Meddahi‐Pellé, A., Anagnostou, F., Barzegari, A., & Pavon‐Djavid, G. (2025) · Methods · doi:10.1016/j.ymeth.2025.03.004 · Cited by 13
Mesenchymal stem cells and their extracellular vesicles: new therapies for cartilage repair
Yang, H., Yang, H., Wang, Q., Ji, H., Qian, T., Qiao, Y., Shi, J., & Meng, C. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1591400 · Cited by 18
Telomerase dynamics in stem cells: Unraveling the molecular nexus of cellular aging and regeneration
Jiang, Y., Zhou, Y., Wang, Y., Li, Z., Ashraf, G. M., & Guo, L. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102853 · Cited by 14
Exploring the Mesenchymal Stem Cell Secretome for Corneal Endothelial Proliferation
den Bogerd, B. V., Zakaria, N., Matthyssen, S., Koppen, C., & Dhubhghaill, S. N. (2020) · Stem Cells International · doi:10.1155/2020/5891393 · Cited by 12
Eshraghi, A. A., Ocak, E., Zhu, A., Mittal, J., Davies, C., Shahal, D., Bulut, E., Sinha, R., Shah, V., Perdomo, M. M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061711 · Cited by 14
Sanie‐Jahromi, F., Nowroozzadeh, M. H., Khodabandeh, Z., Soheili, Z., Khajehahmadi, Z., Emadi, Z., & Talebnejad, M. R. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108528 · Cited by 12
In situ Tissue Regeneration in the Cornea from Bench to Bedside
Poudel, B. K., Robert, M.-C., Simpson, F. C., Malhotra, K., Jacques, L., LaBarre, P., & Griffith, M. (2021) · Cells Tissues Organs · doi:10.1159/000514690 · Cited by 15
Factors Influencing the Therapeutic Potential of the MSC-derived Secretome
Chouw, A., Facicilia, G., Sartika, C. R., Faried, A., & Milanda, T. (2022) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-021-00242-x · Cited by 13
“Different platforms of bioreactors (such as stirred-tank bioreactors, rocking-motion bioreactors, hollow fiber bioreactors, and fix bed bioreactors) are also known to affect the MSC-derived secretome content [26, 41, 68].”
BackgroundRegulation of gingival fibroblast phenotype by periodontal ligament cells in vitro
Garna, D. F., Hughes, F. J., & Ghuman, M. S. (2022) · Journal of Periodontal Research · doi:10.1111/jre.12971 · Cited by 12
Nugraha, A. P., Ramadhani, N. F., Riawan, W., Ihsan, I. S., Ernawati, D. S., Ridwаn, R. D., Narmada, I. B., Saskianti, T., Rezkita, F., Sarasati, A., et al. (2022) · European Journal of Dentistry · doi:10.1055/s-0042-1748529 · Cited by 14
“13,14 The reasons using MSCs for clinical application are: safe, low costs, easy to collect, less tumorigenic, and low immunogenicity.”
Hu, W., Yang, J., Xue, J., Ma, J., Wu, S., Wang, J., Xu, R., Wei, J. J., Wang, Y., Wang, S., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11020463 · Cited by 13
“However, it is well known that MSC-derived secretomes have up to 80% of the therapeutic effects of adult MSCs, which are released by MSCs, which are composed of extracellular vesicles (EVs) and soluble factors in the culture medium (CM) or released into the resident tissues [17,18].”
InfluentialSpontaneous Sepsis in Adult Horses: From Veterinary to Human Medicine Perspectives
Blangy‐Letheule, A., Vergnaud, A., Dupas, T., Rozec, B. R., Lauzier, B., & Leroux, A. (2023) · Cells · doi:10.3390/cells12071052 · Cited by 19
“Thus, the proteins released and their abundance in a given environment can reflect a disease state [99].”
BackgroundKojima, H., Kushige, H., Yagi, H., Nishijima, T., Moritoki, N., Nagoshi, N., Nakano, Y., Tanaka, M., Hori, S., Hasegawa, Y., et al. (2023) · Cell Transplantation · doi:10.1177/09636897231170437 · Cited by 12
Vocal fold restoration after scarring: biocompatibility and efficacy of an MSC-based bioequivalent
Валерьевич, С. М., Shpichka, A. I., Bikmulina, P., Fayzullin, A. L., Владимировна, З. А., Kosheleva, N. V., Валерьевна, С. Л., Shavkuta, B. S., Lobacheva, V. V., Nikiforova, A., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03534-x · Cited by 14
“Kim et al. followed the same tactics when implanting human adipose tissue-derived MSC in the rabbit VF and did not note development of significant immune reactions [49–51].”
BackgroundAzlan, N. A. B. N., Vitus, V., Rashid, N. N., Nordin, F., Tye, G. J., & Zaman, W. S. W. K. (2024) · Cell and Tissue Research · doi:10.1007/s00441-023-03857-4 · Cited by 14
“…or tailor-made cell lines for specific purposes; (f) time and cost effective with regard to expansion and maintenance of cultured stem cells and off-the-shelf secretome therapies for immediate treatments of diseases; (g) the biological product could be cell-specific modified (Vizoso et al. 2017).”
The Great Harmony in Translational Medicine: Biomaterials and Stem Cells
Erten, E., & Arslan, Y. E. (2018) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_231 · Cited by 12
Pelizzo, G., Avanzini, M. A., Mantelli, M., Croce, S., Maltese, A., Vestri, E., SILVESTRI, A. D., Percivalle, E., & Calcaterra, V. (2018) · Journal of Stem Cells and Regenerative Medicine · doi:10.46582/jsrm.1401007 · Cited by 16
“due to their ability to home to and engraft in damaged tissues, release trophic factors, promote neovascularization, manage oxidative stress and trigger anti-inflammatory responses([5,9-12]).”
Winston, T. S., Suddhapas, K., Wang, C., Ramos, R., Soman, P., & Ma, Z. (2019) · Stem Cells International · doi:10.1155/2019/5654324 · Cited by 12
“In the future, we will perform secretome analysis on our hiPSC-MSCs, pursuing a new way of regenerative medicine based on cell-free therapeutic strategies [36].”
MethodProcess development and manufacturing approaches for mesenchymal stem cell therapies
Couto, P. S., Bersenev, A., & Rafiq, Q. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816221-7.00002-1 · Cited by 12
Hingert, D., Nawilaijaroen, P., Aldridge, J., Baranto, A., & Brisby, H. (2019) · Cells Tissues Organs · doi:10.1159/000506350 · Cited by 20
“It has been reported that transplanted cells do not survive for long, but the therapeutic effect observed was due to the vast array of bioactive substances secreted by the cells that played an important role in regulating key biological processes [Vizoso et al., 2017].”
BackgroundMartin, M., Sari, D. S., Mantika, R. A., & Praharani, D. (2021) · Journal of Orofacial Sciences · doi:10.4103/jofs.jofs_157_21 · Cited by 12
“[18-20] Additionally, the studies regarding the combination of Robusta coffee bean extract (RCBE) and DPSC secretome treating periodontitis are still limited.”
BackgroundMethodSimitzi, C., Hendow, E. K., Li, Z., & Day, R. M. (2020) · Advanced Biosystems · doi:10.1002/adbi.202000062 · Cited by 12
Cabezas, J. G., Rojas, D., Wong, Y. S., Tellería, F., Manríquez, J., Mançanares, A. C. F., Rodriguez-Alvarez, L., & Castro, F. O. (2020) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2020.110100 · Cited by 13
Chronic Traumatic Encephalopathy as the Course of Alzheimer’s Disease
Pszczołowska, M., Walczak, K., Miśków, W., Antosz, K., Batko, J., Kurpas, D., & Leszek, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094639 · Cited by 14
“Stem cells may release a paracrine set of regulating molecules like cytokines, chemokines, and growth factors [102].”
BackgroundThe effect of mesenchymal stem cell-conditioned medium gel on burn wound healing in rat
Laksmıtawatı, D. R., Noor, S. U., Sumiyati, Y., Hartanto, A., Widowati, W., & Pratamı, D. K. (2022) · Veterinary World · doi:10.14202/vetworld.2022.841-847 · Cited by 11
“The other stem cell mechanism of action is the secretion of bioactive factors, which may affect both systemic and local physiological processes [8].”
BackgroundSalkın, H., Acar, M. B., Korkmaz, Ş., Gunaydin, Z., Gönen, Z. B., Başaran, K. E., & Özcan, S. (2022) · Journal of Dentistry · doi:10.1016/j.jdent.2022.104224 · Cited by 14
Csöbönyeiová, M., Smolinská, V., Harsányi, Š., Ivantysyn, M., & Klein, M. (2023) · Biomedicines · doi:10.3390/biomedicines11061736 · Cited by 11
“Due to their unique ability to interact with recipient cells, the use of exosomes is preferable over the use of CM, and in recent years, they have been increasingly applied in the treatment of several diseases [60].”
BackgroundXie, W., Luo, T., Ma, Z., Xue, S., Jia, X., Yang, T., & Song, Z. (2023) · Tissue Engineering Part A · doi:10.1089/ten.tea.2023.0139 · Cited by 11
“67 Therefore, MSC-derived EVs may be a good option for the treatment of SAP.”
Managing Temporomandibular Joint Osteoarthritis by Dental Stem Cell Secretome
Bousnaki, M., Bakopoulou, A., Grivas, I. N., Bekiari, C., Pich, A., Rizk, M., Keklikoglou, K., Papachristou, E., Papadopoulos, G. C., Κritis, A., et al. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10628-9 · Cited by 11
“Cell-free approaches such as those involving the MSC-SECR have become more popular than cell-based treatments due to ease of processing, lower manufacturing cost, storage, non-immunogenicity, and non-tumorogenicity [12].”
MethodUtilizing stem cell-secreted molecules as a versatile toolbox for skin regenerative medicine
Zheng, J., Park, K., Jang, J., Son, D., Park, J., Kim, J., Yoo, J.-E., You, S., & Kim, I.-Y. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.05.009 · Cited by 12
Wu, L., Zhang, L., Huang, M., Wu, Y. L., Jin, S., Zhang, Y., Gan, X., Yu, T., Yu, G., Zhang, J., et al. (2024) · Biomolecules · doi:10.3390/biom14111353 · Cited by 13
Dental Pulp Stem Cell Conditioned Medium Enhance Osteoblastic Differentiation and Bone Regeneration
Chouaib, B., Desoutter, A., Cuisinier, F., & Collart-Dutilleul, P.-Y. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10823-2 · Cited by 11
Emerging Treatments for Persistent Corneal Epithelial Defects
Kwon, J. (., Kang, C., Moghtader, A., Shahjahan, S., Bibak-Bejandi, Z., Alzein, A. F., & Djalilian, A. R. (2025) · Vision · doi:10.3390/vision9020026 · Cited by 11
“In fact, secretomes have a higher safety profile with low risk of infection, less time needed for expansion, and lower cost in production [147].”
Tan, J., Yunxia, H., Zheng, L., Zheng, Z., Fu, M., Peng, H., & Ma, S. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70053 · Cited by 11
“Extracellular vesicle (EV) is a type of nanoscale membrane vesicles actively secreted by living cells, which carry biomolecules such as proteins, RNA and DNA from the parent cell and play a crucial role in intercellular communication (Giebel et al. 2017; Vizoso et al. 2017).”
Research progress on exosomes derived from mesenchymal stem cells in hematological malignancies
Lyu, T., Zhang, B., Li, M., Jiao, X., & Song, Y. (2020) · Hematological Oncology · doi:10.1002/hon.2793 · Cited by 12
Du, Y., Zong, M., Guan, Q., Huang, Z., Zhou, L., Cai, J., da Roza, G., Wang, H., Qi, H., Lu, Y., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02473-9 · Cited by 12
Pinheiro, D., Dias, I. X., Freire, T., Thole, A. A., Stumbo, A. C., Cortez, E. A. C., de Carvalho, L., & de Carvalho, S. N. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119768 · Cited by 13
Senthilkumar, S., Maiya, K., Jain, N. K., Mata, S., Mangaonkar, S., Prabhu, P., Rai, K. S., Kutty, B. M., & Dhanushkodi, A. (2022) · Current Gene Therapy · doi:10.2174/1566523223666221027113723 · Cited by 12
Kim, M. S., Kong, D., Han, M., Roh, K.-H., Koo, H., Lee, S., & Kang, K. (2023) · Veterinary Research Communications · doi:10.1007/s11259-023-10155-5 · Cited by 11
“More effective and disease-specific therapies can be created with a better understanding of the biological mechanisms that comprise the secretome in relation to its tissue source (Vizoso et al. 2017).”
Backgroundvan der Koog, L., Boerrigter, M. J., Gorter, I. C., Gosens, R., & Nagelkerke, A. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176612 · Cited by 14
“…identified enrichment of growth factors and cytokines that are involved in proliferation, anti-oxidation, anti-apoptosis, angiogenesis, immunomodulation, regeneration, and endo-peptidase inhibitors, in the secretome of mesenchymal cells (Bari et al., 2019; Hung et al., 2007; Vizoso et al., 2017).”
BackgroundMicroRNA Profiling of HL-1 Cardiac Cells-Derived Extracellular Vesicles
Silvestro, S., Gugliandolo, A., Chiricosta, L., Diomede, F., Trubiani, O., Bramanti, P., Pizzicannella, J., & Mazzon, E. (2021) · Cells · doi:10.3390/cells10020273 · Cited by 11
“In recent studies, the paracrine effects of mesenchymal stem cells are considered to be the main reason for their regenerative potential; therefore, the focus has been on extracellular vesicles (EVs) and the bioactive molecules they contain [1,2].”
BackgroundEndometrial Regenerative Cell-Derived Conditioned Medium Alleviates Experimental Colitis
Sun, C., Hao, J., Qin, H., Zhu, Y., Li, X., Zhang, B., Qin, Y., Li, G., Wang, H., & Wang, H. (2022) · Stem Cells International · doi:10.1155/2022/7842296 · Cited by 11
“Therefore, due to the characteristics of MSCs and the existence of various limitations, the cell-free treatment strategy is on the rise and has several advantages over cell therapy, as they can be obtained more easily and more economically and can be manufactured, packaged, and transported straightforwardly [28], and…”
BackgroundSu, Y., Ai, S., Shen, Y., Cheng, W., Xu, C., Sui, L., & Zhao, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086981 · Cited by 10
“The MSC-derived secretome is a cell-free therapy strategy that can effectively avoid the problems of the direct use of MSCs and provide more advantages over MSC-based applications, such as avoiding potential safety risks associated with cell transplantations and facilitating the evaluation of safety, dosage and potenc…”
BackgroundHao, X., Guo, Y., Yu, X., He, L., He, Y., & Shu, M. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102575 · Cited by 10
Multiple strategies enhance the efficacy of MSC-Exos transplantation for spinal cord injury
Xu, Y., Wang, X., Zhou, X., Zeng, W., Yuan, J., & Ye, J. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115038 · Cited by 13
Zhang, L., Yuan, X., Song, R., Yuan, Z., Zhao, Y., & Zhang, Y. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.04.008 · Cited by 15
Chin, J. S., Tan, M. L. L., Lim, P. L. K., Sharma, B., Yeo, A., Aw, Y. B., Ng, Y. Z., Bonnard, C., Becker, D. L., & Mok, P. (2025) · International Wound Journal · doi:10.1111/iwj.70033 · Cited by 10
“16,17 An attractive alternative to the direct use of MSCs are products containing their paracrine factors instead, which may include the whole secretome or a subset such as the exosomes.”
Ma, Y., Liu, T., Li, P. A., Cao, L., Lu, X., & Wang, H. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04517-w · Cited by 12
“Upon further investigation into MSC-Exo, researchers discovered that they presented an ideal approach to address numerous challenges encountered in clinical cell transplantation, such as issues of immunocompatibility, tumorigenicity, and the occurrence of embolism [34, 35].”
Advances in extracellular vesicle-based nanomedicine for regenerative orthopaedics
Izquierdo, S. G., Pilar, A. F., Rios, J. L., Lim, K. S., Toh, W. S., Liu, C., Gimona, M., Gawlitta, D., & Man, K. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03906-w · Cited by 13
“Interest-ingly, growing evidence suggests that the bioactive factors secreted by MSCs play a key role in their therapeutic effects, prompting researchers to explore the use of these cell-derived trophic factors for regenerative applications [21, 22].”
The versatility of mesenchymal stem cells: From regenerative medicine to COVID, what is next?
Paim, T. C., & Wink, M. R. (2021) · Biocell · doi:10.32604/biocell.2022.018498 · Cited by 10
Shape memory engineered scaffold (SMES) for potential repair of neural tube defects
Pisani, S., Calcaterra, V., Croce, S., Dorati, R., Bruni, G., Genta, I., Avanzini, A., Benazzo, M., Pelizzo, G., & Conti, B. (2022) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2022.105223 · Cited by 10
Poly (L-Lactic Acid) Cell-Laden Scaffolds Applied on Swine Model of Tracheal Fistula
Manzini, B. M., Dávila, J. L., Volpe, B. B., Duarte, A. S. S., Côrtes, M. T. F., Duek, E. A. D. R., Fávaro, W. J., d’Ávila, M. A., Mussi, R. K., & Luzo, Â. C. M. (2022) · Journal of Surgical Research · doi:10.1016/j.jss.2022.03.024 · Cited by 10
Park, Y. M., Yang, C. M., & Cho, H. Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136877 · Cited by 11
“It has been previously shown that stem cell-secreted growth factors and cytokines promote tissue regeneration and recovery [34,35].”
BackgroundBibliometric and visualization analysis of literature relating to diabetic erectile dysfunction
Meng, F., Liao, X., Chen, H., Deng, S., Wang, L., Zhao, M., Li, H., Liu, D., Gao, G., Li, H., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1091999 · Cited by 10
Pour, F. K., Dari, M. A. G., Ramazii, M., Keivan, M., & Farzaneh, M. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x18666221219163753 · Cited by 11
Semita, I. N., Utomo, D. N., & Suroto, H. (2023) · World Journal of Orthopedics · doi:10.5312/wjo.v14.i2.64 · Cited by 10
Bioengineered extracellular vesicles: future of precision medicine for sepsis
Areny‐Balagueró, A., Solé‐Porta, A., Camprubí–Rimblas, M., Campaña-Duel, E., Ceccato, A., Roig, A., Closa, D., & Artigas, A. (2023) · Intensive Care Medicine Experimental · doi:10.1186/s40635-023-00491-w · Cited by 10
“One of the most prominent strategy shown to significantly modify EVs intraluminal cargo, increase EVs secretion and enhance EVs potency is the alteration of parental cells cell-culture parameters [95, 96].”
BackgroundLaloze, J., Lacoste, M., Marouf, F., Carpentier, G., Vignaud, L., Chaput, B., Varin, A., Desmoulière, A., & Rovini, A. M. F. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134214 · Cited by 10
“Modification of the key biological processes is possible in order to better target the desired effects on cells [30].”
BackgroundAdvances in the applications of mesenchymal stem cell-conditioned medium in ocular diseases
Zhang, C., Xiao, J., Fa, L., Jiang, F., Jiang, H., Zhou, L., & Xu, Z. (2023) · Experimental Eye Research · doi:10.1016/j.exer.2023.109560 · Cited by 12
Djatche, W. H. B., Zhu, H., Ma, W., Li, Y., Li, Z., Zhao, H., Liu, Z., & Qiao, H. (2023) · Regenerative Medicine · doi:10.2217/rme-2023-0089 · Cited by 12
Olcar, H. N., Işıldar, B., Özkan, S., Erçin, M., Gezginci-Oktayoğlu, S., & Koyutürk, M. (2023) · Microscopy Research and Technique · doi:10.1002/jemt.24420 · Cited by 11
“It is known that these factors are also present in the secretome secreted by MSCs and that MSCs thus increase proliferation and migration and inhibit apoptosis (Vizoso et al., 2017).”
BackgroundNew era of mesenchymal stem cell-based medicine: basis, challenges and prospects
Vizoso, F. J., Costa, L. A. M. D., & Eiró, N. (2023) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2023.11.002 · Cited by 15
Self-citationEiró, N., Fraile, M., Escudero-Cernuda, S., Sendón-Lago, J., González, L. O., Fernández‐Sánchez, M. L., & Vizoso, F. J. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03717-0 · Cited by 11
“…assessment, dosage and potency to conventional pharmaceutical agents; (iii) offers easy storage; (iv) offers a more practical and cheaper clinical application; (v) allows the biological product obtained for therapeutic applications to be modified to suit the patient’s needs, among others [26].”
BackgroundSelf-citationZhou, L., Zong, M., Guan, Q., da Roza, G., Wang, H., Qi, H., & Du, C. (2019) · Stem Cells International · doi:10.1155/2019/8793640 · Cited by 11
“It has been considered that the secretome is a primary means by which MSCs conduct many of their therapeutic e ff ects [47].”
Forouzandeh, M., Bigdeli, M. R., Mostafavi, H., Nadri, S., & Eskandari, M. (2021) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2021.104703 · Cited by 10
Eiró, N., Sendón-Lago, J., Cid, S., Saá, J., de Pablo, N., Vega, B., Bermúdez, M. A., Pérez-Fernández, R., & Vizoso, F. J. (2022) · Ophthalmic Research · doi:10.1159/000524484 · Cited by 10
Self-citationLin, T.-J., Huang, Y.-L., Kang, Y., & Chen, C. (2022) · Aesthetic Plastic Surgery · doi:10.1007/s00266-022-03168-z · Cited by 10
“For instance, MSC secretome has notable capabilities such as immunomodulation, anti-inflammation, antiapoptosis, wound healing, tissue repair, neuroprotection, and angiogenesis regulation [43].”
BackgroundYasumura, Y., Teshima, T., Nagashima, T., Takano, T., Michishita, M., Taira, Y., Suzuki, R. H., & Matsumoto, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032250 · Cited by 11
Palumbo, F. S., Fiorica, C., Carreca, A. P., Iannolo, G., Pitarresi, G. L., Amico, G., Giammona, G., Conaldi, P. G., & Chinnici, C. M. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.123904 · Cited by 9
Rastogi, M., Sahu, K., & Majumder, S. K. (2025) · Lasers in Medical Science · doi:10.1007/s10103-025-04339-5 · Cited by 11
“Various priming strategies have been explored to modulate SC proliferation, differentiation and enhance secretome pro - duction [1, 5].”
Zhang, J., Wang, C., Yang, G., Zhou, Y., Hou, D., & Xia, Y. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-025-10009-7 · Cited by 13
In Vitro Assessment of Cytokine Expression Profile of MCF-7 Cells inResponse to hWJ-MSCs Secretome
Mirabdollahi, M., Javanmard, S. H., & Sadeghi‐Aliabadi, H. (2019) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2019.075 · Cited by 10
Giuliani, A., Sena, G., Tromba, G., Mazzon, E., Fontana, A., Diomede, F., Piattelli, A., & Trubiani, O. (2020) · Applied Sciences · doi:10.3390/app10072336 · Cited by 9
“However, another advantage in using MSCs for bone engineering is linked to their capacity to release different factors, including growth factors, soluble proteins and free nucleic acids [30]; specifically, the conditioned medium (CM) contains different growth factors secreted by MSCs, possibly very useful for regenera…”
BackgroundCeruso, A., Gonzalez‐Pujana, A., Igartua, M., Santos‐Vizcaíno, E., & Hernández, R. M. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00934-5 · Cited by 10
Metadata
- Authors
- Vizoso, F., Eiro, N., Cid, S., Schneider, J., & Perez-Fernandez, R.
- Affiliations
- Fundación Hospital de Jove (ES)
- Research Unit, Fundación Hospital de Jove, Avda. Eduardo Castro, 161, 33290 Gijón, Spain
- Department of Obstetrics & Gynecology, C/Ramon y Cajal 7, University of Valladolid, 47005 Valladolid, Spain
- Department of Physiology-Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, 15706 Santiago de Compostela, Spain
- Corresponding author
- Vizoso, Francisco
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-08-25
- Volume
- 18
- Issue
- 9
- Pages
- 1852
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5618501
- OpenAlex
- W2746710261
- Cited by
- 1,363
- References
- 235
- Citations by year
- 2026: 142 · 2025: 165 · 2024: 153 · 2023: 182 · 2022: 186 · 2021: 178 · 2020: 158 · 2019: 130 · 2018: 62 · 2017: 6
- FWCI
- 13.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Science Council
- European Regional Development Fund (SAF2015-69221-R)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- mesenchymal stem cells, secretome, cell-free therapy, conditioned medium, exosomes, regenerative medicine, stem cell therapy, quality control, regulatory requirements
- MeSH terms
- Clinical Studies as Topic, Animals, Humans, Stem Cells, Culture Media, Conditioned, Regenerative Medicine, Mesenchymal Stem Cell Transplantation, Cell-Derived Microparticles, Exosomes, Mesenchymal Stem Cells, Cell- and Tissue-Based Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.